Actively Recruiting
Study of Lysoveta Krill Oil Versus Placebo for Memory in Healthy Adults Aged 50 to 75 with Memory Concerns
Led by Aker BioMarine Human Ingredients AS · Updated on 2026-07-08
138
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the effects of Lysoveta, a hydrolyzed krill oil supplement rich in omega-3 fatty acids, on cognitive function in healthy adults aged 50 to 75 who experience self-perceived memory problems. This randomized, placebo-controlled, triple-blind trial aims to compare the impact of Lysoveta versus a placebo on episodic, working, and spatial memory using the Computerized Mental Performance Assessment System COMPASS. Participants are randomly assigned to one of two groups one group receives three capsules daily containing 500 mg each of Lysoveta, while the other group takes placebo capsules containing a mix of medium-chain triglyceride, maize, olive, and palm kernel oils. The study lasts for 112 days, during which participants complete questionnaires to assess cognitive performance and mood. Throughout the trial, participants undergo various assessments including memory, executive function, reaction time, mood, omega-3 status, and serum brain-derived neurotrophic factor BDNF levels. They will complete questionnaires, records, and diaries related to their cognitive and mood status. Safety and adherence are monitored, and the main outcome is the change in memory performance from baseline to day 112.
CONDITIONS
Brief Title
A Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems
Research Team
M
Marc Moulin, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
